OpGen
In Brief This Week: Labcorp, Lucid Diagnostics, Seegene, Babson Diagnostics, Danaher, More
News items for the in vitro diagnostics industry for the week of May 8, 2022.
In Brief This Week: Qiagen, Renalytix, OpGen, PerkinElmer, Avacta, Paige, More
News items for the in vitro diagnostics industry for the week of April 4, 2022.
OpGen Q4 Revenues Flat on Modest Product Sale Gains
The company's revenues were essentially unchanged year over year as a modest uptick in product sales was partially offset by declining collaboration revenue.
The company is seeking to drive clinical uptake of the Acuitas AMR panel while bringing complementary offerings from its subsidiary Ares Genetics to the US.
CareDx, Castle Bio, Lucira Health, Others Announce Preliminary Q4, FY21 Earnings Results
CareDx's Q4 revenues rose between 34 percent and 35 percent, while OpGen Q4 revenues were flat compared to the previous year.
Nov 12, 2021
OpGen Q3 Revenues Climb 9 Percent
Aug 12, 2021
OpGen Q2 Revenues Fall 32 Percent
Mar 25, 2021
OpGen Fourth Quarter Revenues Increase 64 Percent
Feb 9, 2021
OpGen Enters $25M Direct Offering Agreement
Jan 13, 2021
OpGen Preliminary Q4 Revenue Climbs 63 Percent
Nov 24, 2020